Labcorp Holdings Other Non-Current Liabilities increased by 6.8% to $691.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.9%, from $497.90M to $691.80M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 4.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $502.90M | $494.00M | $402.00M | $489.80M | $484.50M | $433.90M | $401.10M | $413.60M | $418.50M | $423.00M | $409.30M | $468.20M | $483.90M | $528.20M | $517.40M | $497.90M | $643.20M | $639.10M | $647.80M | $691.80M |
| QoQ Change | — | -1.8% | -18.6% | +21.8% | -1.1% | -10.4% | -7.6% | +3.1% | +1.2% | +1.1% | -3.2% | +14.4% | +3.4% | +9.2% | -2.0% | -3.8% | +29.2% | -0.6% | +1.4% | +6.8% |
| YoY Change | — | — | — | — | -3.7% | -12.2% | -0.2% | -15.6% | -13.6% | -2.5% | +2.0% | +13.2% | +15.6% | +24.9% | +26.4% | +6.3% | +32.9% | +21.0% | +25.2% | +38.9% |